Dual antiplatelet therapy (DAT) was associated with an increased haemorrhage risk after drug-eluting stent (DES) placement

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1632, 2008-01, pp. : 25-25

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term clopidogrel beneficial after drug-eluting stent placement

By  

Inpharma, Vol. 1, Iss. 1567, 2006-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite

Deciphering Dual Antiplatelet Therapy in the Era of Drug-Eluting Coronary Stents

By  

Current Drug Targets, Vol. 10, Iss. 6, 2009-06 ,pp. : 519-529

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Antiplatelet Therapy after Percutaneous Coronary Intervention with Bare-Metal Stents and Different Types of Drug-Eluting Stents

By  

Current Clinical Pharmacology, Vol. 8, Iss. 1, 2013-02 ,pp. : 59-66

Bentham Science Publishers

Access to resources Recommend Favorite

Paclitaxel: False aneurysm following placement of drug-eluting stent: case report

By  

Reactions Weekly, Vol. 1, Iss. 1213, 2008-01 ,pp. : 27-27

Adis International

Access to resources Recommend Favorite

Sirolimus: Late restenosis following drug-eluting stent placement: case report

By  

Reactions Weekly, Vol. 1, Iss. 1146-1147, 2007-01 ,pp. : 23-23

Adis International

Access to resources Recommend Favorite